- Home
- THRD vs GDEV Comparison
THRD vs GDEV Comparison
Compare THRD & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- GDEV
- Stock Information
- Founded
- THRD 2019
- GDEV 2009
- Country
- THRD United States
- GDEV Cyprus
- Employees
- THRD N/A
- GDEV N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- THRD Health Care
- GDEV Technology
- Exchange
- THRD Nasdaq
- GDEV Nasdaq
- Market Cap
- THRD 232.4M
- GDEV 268.7M
- IPO Year
- THRD 2022
- GDEV N/A
- Fundamental
- Price
- THRD $5.25
- GDEV $16.19
- Analyst Decision
- THRD Hold
- GDEV Buy
- Analyst Count
- THRD 3
- GDEV 2
- Target Price
- THRD $5.00
- GDEV $70.00
- AVG Volume (30 Days)
- THRD 296.2K
- GDEV 18.3K
- Earning Date
- THRD 05-08-2025
- GDEV 05-16-2025
- Dividend Yield
- THRD N/A
- GDEV N/A
- EPS Growth
- THRD N/A
- GDEV N/A
- EPS
- THRD N/A
- GDEV 1.38
- Revenue
- THRD N/A
- GDEV $420,933,000.00
- Revenue This Year
- THRD N/A
- GDEV N/A
- Revenue Next Year
- THRD N/A
- GDEV $12.39
- P/E Ratio
- THRD N/A
- GDEV $11.88
- Revenue Growth
- THRD N/A
- GDEV N/A
- 52 Week Low
- THRD $3.18
- GDEV $8.60
- 52 Week High
- THRD $16.02
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- THRD 75.64
- GDEV 59.48
- Support Level
- THRD $5.16
- GDEV $14.91
- Resistance Level
- THRD $5.22
- GDEV $15.60
- Average True Range (ATR)
- THRD 0.04
- GDEV 0.78
- MACD
- THRD -0.03
- GDEV -0.08
- Stochastic Oscillator
- THRD 100.00
- GDEV 75.47
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.